Etiopathogenesis and pathophysiology of type 2 diabetes;Etiopathogénie et physiopathologie du diabète de type 2

Revue Medicale de Liege

Volumn 60, Issue 5-6, 2005, Pages 361-368

  Fery F ^a   Paquot, N ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Etiopathogenesis; Genetics; Insulin resistance; Insulin secretion; Pathophysiology; Type 2 diabetes

Indexed keywords

FAT; FATTY ACID; GLUCOSE;

ABDOMEN; ADIPOSE TISSUE; DIABETOGENESIS; FATTY ACID BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIFESTYLE; LIPOLYSIS; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW; SKELETAL MUSCLE; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; EXERCISE; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; OBESITY; RISK FACTORS;

EID: 21744439128     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H.- Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia, 1999, 42, 139-145.
2. O'Rahilly S, Barroso I, Wareham NJ- Genetic factors in type 2 diabetes: the end of the beginning? Science, 2005, 307, 370-373.
3. Horikawa Y, Oda N, Cox NJ, et al.- Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet, 2000, 26, 163-175.
4. Hu FB, Manson JE, Stampfer MJ, et al.- Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med, 2001, 345, 790-797.
5. West KM, Kalbfleisch JM.- Influence of nutritional factors on prevalence of diabetes. Diabetes, 1971, 20, 99-108.
6. Bell GI, Polonsky KS.- Diabetes mellitus and genetically programmed defects in beta-cell function. Nature, 2001, 414, 788-791.
7. Bergman RN, Phillips LS, Cobelli C.- Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest, 1981, 68, 1456-1467.
8. Kahn SE, Prigeon RL, McCulloch DK, et al.- Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes, 1993, 42, 1663-1672.
9. Clausen JO, Borch-Johnsen K, Ibsen H, et al.- Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest, 1996, 98, 1195-1209.
10. Stumvoll M, Tataranni PA, Stefan N, et al.- Glucose allostasis. Diabetes, 2003, 52, 903-909.
11. Hu FB, Sigal RJ, Rich-Edwards JW, et al.- Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA, 1999, 282, 1433-1439.
12. Hales CN, Barker DJ.- Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia, 1992, 35, 595-601.
13. Weedon MN, Frayling TM, Shields B, et al.- Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes, 2005, 54, 576-581.
14. Neel JV.- Diabetes mellitus:a "thrifty" genotype rendered detrimental by "progress"? Am JHum Genet, 1962, 14, 353-362.
15. Knowler WC, Pettitt DJ, Savage PJ, Bennett PH.} Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol, 1981, 113, 144-156.
16. Rothman DL, Magnusson I, Cline G, et al.- Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA, 1995, 92, 983-987.
17. Shepherd PR, Kahn BB.- Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med, 1999, 341, 248-257.
18. Perseghin G, Scifo P, De Cobelli F, et al.- Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes, 1999, 48, 1600-1606.
19. Petersen KF, Dufour S, Befroy D, et al.- Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med, 2004, 350, 664-667.
20. Petersen KF, Befroy D, Dufour S, et al.- Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science, 2003, 300, 1140-1142.
21. Lillioja S, Mott DM, Zawadzki JK, et al.- In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes, 1987, 36, 1329-1335.
22. Martin BC, Warram JH, Rosner B, et al.- Familial clustering of insulin sensitivity. Diabetes, 1992, 41, 850-854.
23. Poulsen P, Levin K, Petersen I, et al.- Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes, 2005, 54, 275-283.
24. Shulman GI.- Cellular mechanisms of insulin resistance. J Clin Invest, 2000, 106, 171-176.
25. Ryysy L, Hakkinen AM, Goto T, et al.- Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes, 2000, 49, 749-758.
26. Laakso M, Edelman SV, Brechtel G, Baron AD.- Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes, 1992, 41, 1076-1083.
27. O'Rahilly S, Turner RC, Matthews DR.- Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med. 1988, 318, 1225-1230.
28. Pfeifer MA, Halter JB, Porte D Jr.- Insulin secretion in diabetes mellitus. Am J Med, 1981, 70, 579-588.
29. Ward WK, Bolgiano DC, McKnight B, et al.- Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest, 1984, 74, 1318-1328.
30. Saad MF, Kahn SE, Nelson RG, et al.- Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1990, 70, 1247-1253.
31. Nauck MA, Siegel EG, Creutzfeldt W.- Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas, 1991, 6, 645-652.
32. Ehrmann DA, Sturis J, Byrne MM, et al.- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest, 1995, 96, 520-527.
33. Ryan EA, Imes S, Liu D, McManus R, et al.- Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes, 1995, 44, 506-512.
34. Ferrannini E, Gastaldelli A, Miyazaki Y, et al.- Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab, 2005, 90, 493-500.
35. U.K. Prospective Diabetes Study Group.- U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes. 1995, 44, 1249-1258.
36. Butler AE, Janson J, Bonner-Weir S, et al.- β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes, 2003, 52, 102-110.
37. Rhodes CJ.- Type 2 diabetes-a matter of beta-cell life and death? Science, 2005, 307, 380-384.
38. Hull RL, Westermark GT, Westermark P, Kahn SE.- Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab, 2004, 89, 3629-3643.
39. Maedler K, Sergeev P, Ris F, Oberholzer J, et al.- Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest, 2002, 110, 851-860.
40. Kulkarni RN, Bruning JC, Winnay JN, et al.- Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell, 1999, 96, 329-339.
41. Elders MJ, Schedewie HK, Olefsky J, et al.- Endocrine-metabolic relationships in patients with leprechaunism. J Natl Med Assoc, 1982, 74, 1195-1210.
42. Weyer C, Bogardus C, Mott DM, Pratley RE.- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest, 1999, 104, 787-794.